Cath Lab

The catheterization lab channel includes content related to interventional technologies for coronary and peripheral artery disease (PAD). Other cath lab transcatheter device technologies covered on this page included percutaneous treatment for stroke, venous interventions, heart valves, hypertensionheart failure and percutenous coronary interventions (PCI).

U.S. CoreValve High Risk trial TCT 2014
Feature

September 19, 2014 — According to a new study, transcatheter aortic valve replacement (TAVR) provided meaningful ...

Home September 19, 2014
Home
Study Blood Thinner Heart Attack Patients
Feature

September 19, 2014 — The largest prospective longitudinal study of acute myocardial infarction (MI) patients offers ...

Home September 19, 2014
Home
Feature

September 19, 2014 — A new study investigating different durations of triple therapy for anticoagulation after drug ...

Home September 19, 2014
Home
Feature

September 19, 2014 — According to a new study, peritoneal hypothermia is feasible for patients who have suffered ST ...

Home September 19, 2014
Home
News

September 18, 2014 — New data from a landmark clinical trial found that after five years, transcatheter aortic valve ...

Home September 18, 2014
Home
News

September 18, 2014 — A new study found that fractional flow reserve (FFR)-guided provisional side branch (SB) stenting ...

Home September 18, 2014
Home
Feature

September 17, 2014 — A new clinical trial found that vascular closure devices (VCDs) are non-inferior to manual ...

Home September 17, 2014
Home
Technology

September 17, 2014 — GE Healthcare announced it has installed its Cath Lab Efficiency Manager at Saint Luke’s Mid ...

Home September 17, 2014
Home
News

September 16, 2014 — A quarter of adults in the United States have two or more chronic medical conditions, as do more ...

Home September 16, 2014
Home
News

September 16, 2014 — Tryton Medical Inc. announced that the first patient in the United States has been enrolled in the ...

Home September 16, 2014
Home
News

September 15, 2014 — St. Jude Medical Inc. announced primary outcome two-year data from the FAME 2 clinical trial, which ...

Home September 15, 2014
Home
News

September 12, 2014 — Volcano Corp. announced it will be launching its interventional precision guidance tools at the ...

Home September 12, 2014
Home
Technology

September 11, 2014 — Medtronic announced the U.S. Food and Drug Administration (FDA) 510(k) clearance and launch of the ...

Home September 11, 2014
Home
News

September 11, 2014 — U.S.-based Medtronic said it would purchase Ireland-based Covidien for $42.9 billion, combining two ...

Home September 11, 2014
Home
News
Transcatheter Cardiovascular Therapeutics (TCT) has announced the late-breaking trial presentations at TCT 2014, Sept ...
Home September 09, 2014
Home
Subscribe Now